Nat Sciver-Brunt

1. Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

   · 2005 · cited 9,346x

2. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

   · 2017 · cited 6,044x

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

   · 2021 · cited 4,135x

4. Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

   · 1999 · cited 3,162x

5. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

   · 2012 · cited 2,883x

via Crossref · CC0

via Wikidata sitelinks · CC0